Second pass at: Pharmacy supply in the UK and the questions you will be asked Writing it up because I had to work it out twice and would rather nobody else did.
Asking about Pharmacy supply on behalf of the question I keep seeing asked badly, including by me.
Framed properly it is answerable. Framed the usual way it is not, and that is most of why the previous threads went nowhere.
The honest answer on Pharmacy supply is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.
Most people get the first two right and then argue about the fourth.
Taking the opening post at face value and following it one step further.
Date the claim and say whether it is the United Kingdom or Ireland. They are different regulatory jurisdictions and the answer is frequently different.
Post #5 answers the question as asked. The question underneath it is different.
I read the earlier replies on Pharmacy supply twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected.
Clinical guidance published for prescribers is public and answers most eligibility questions here more precisely than the discussion does.
Take the reasoning and check the arithmetic; I do not always get it right.
I would call the community position on Pharmacy supply likely rather than established, and I would be comfortable defending that hedge.
Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating.
I keep a log of this specifically because memory is unreliable about it.
Where a member reports a decision, the useful detail is the stated reason rather than the outcome, because the reason is what generalises.
One case, stated as one case.
Post #12 describes the usual case. This is about the unusual one.
Where the compound is supplied with a device, the device and the compound have separate availability positions and the device is more often the constraint.
The version of Pharmacy supply that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those conditions are where the interesting cases live.
Post #18 answers the question as asked. The question underneath it is different.
On Pharmacy supply: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here including this one.
I read post #16 twice before replying, because I had assumed the opposite.
Answering the Pharmacy supply question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first measurement was taken.
Everything in post #21 holds. The case it does not cover is the one I have.
Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
The version of Pharmacy supply that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Whatever the answer on Pharmacy supply turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
I read post #25 twice before replying, because I had assumed the opposite.
Where guidance distinguishes between indications, quoting the indication is essential. The same compound has different positions under different indications.
Post #25 answers the question as asked. The question underneath it is different.
Waiting times are the most variable and least generalisable thing reported here, and they are worth posting anyway with a region and a date.
I had written a reply contradicting post #25 and deleted it. Here is what survived.
Adding a small correction to the Pharmacy supply summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history.
The honest answer is that it depends, and here is what it depends on.